Literature DB >> 11136257

Unusual resistance of ALR/Lt mouse beta cells to autoimmune destruction: role for beta cell-expressed resistance determinants.

C E Mathews1, R T Graser, A Savinov, D V Serreze, E H Leiter.   

Abstract

Genetic analysis of autoimmune insulin-dependent diabetes mellitus (IDDM) has focused on genes controlling immune functions, with little investigation of innate susceptibility determinants expressed at the level of target beta cells. The Alloxan (AL) Resistant (R) Leiter (Lt) mouse strain, closely related to the IDDM-prone nonobese diabetic (NOD)/Lt strain, demonstrates the importance of such determinants. ALR mice are unusual in their high constitutive expression of molecules associated with dissipation of free-radical stress systemically and at the beta-cell level. ALR islets were found to be remarkably resistant to two different combinations of beta-cytotoxic cytokines (IL-1beta, tumor necrosis factor alpha, and IFN-gamma) that destroyed islets from the related NOD and alloxan-susceptible strains. The close MHC relatedness between the NOD and ALR strains (H2-Kd and H2-Ag7 identical) allowed us to examine whether ALR islet cells could survive autoimmune destruction by NOD-derived Kd-restricted diabetogenic cytotoxic T lymphocyte clones (AI4 and the insulin-reactive G9C8 clones). Both clones killed islet cells from all Kd-expressing strains except ALR. ALR resistance to diabetogenic immune systems was determined in vivo by means of adoptive transfer of the G9C8 clone or by chimerizing lethally irradiated ALR or reciprocal (ALR x NOD)F1 recipients with NOD bone marrow. In all in vivo systems, ALR and F1 female recipients of NOD marrow remained IDDM free; in contrast, all of the NOD recipients became diabetic. In conclusion, the ALR mouse presents a unique opportunity to identify dominant IDDM resistance determinants expressed at the beta cell level.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11136257      PMCID: PMC14574          DOI: 10.1073/pnas.98.1.235

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Insulin expression in the thymus, tolerance, and type 1 diabetes.

Authors:  A Pugliese
Journal:  Diabetes Metab Rev       Date:  1998-12

2.  C-JUN/AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells.

Authors:  N Singh; Y Sun; K Nakamura; M R Smith; N H Colburn
Journal:  Oncol Res       Date:  1995       Impact factor: 5.574

3.  Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.

Authors:  A Rabinovitch; W Suarez-Pinzon; K Strynadka; Q Ju; D Edelstein; M Brownlee; G S Korbutt; R V Rajotte
Journal:  Diabetes       Date:  1999-06       Impact factor: 9.461

4.  MHC class I-mediated antigen presentation and induction of CD8+ cytotoxic T-cell responses in autoimmune diabetes-prone NOD mice.

Authors:  D V Serreze; W S Gallichan; D P Snider; K Croitoru; K L Rosenthal; E H Leiter; G J Christianson; M E Dudley; D C Roopenian
Journal:  Diabetes       Date:  1996-07       Impact factor: 9.461

5.  Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.

Authors:  D L Eizirik; S Sandler; A Hallberg; K Bendtzen; A Sener; W J Malaisse
Journal:  Endocrinology       Date:  1989-08       Impact factor: 4.736

6.  Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement.

Authors:  T P DiLorenzo; R T Graser; T Ono; G J Christianson; H D Chapman; D C Roopenian; S G Nathenson; D V Serreze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

7.  Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.

Authors:  I C Gerling; D V Serreze; S W Christianson; E H Leiter
Journal:  Diabetes       Date:  1992-12       Impact factor: 9.461

8.  Nuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cells.

Authors:  R U Jänicke; F H Lee; A G Porter
Journal:  Mol Cell Biol       Date:  1994-09       Impact factor: 4.272

Review 9.  An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus.

Authors:  A Rabinovitch
Journal:  Diabetes Metab Rev       Date:  1998-06

10.  Pancreatic beta cell-specific expression of thioredoxin, an antioxidative and antiapoptotic protein, prevents autoimmune and streptozotocin-induced diabetes.

Authors:  M Hotta; F Tashiro; H Ikegami; H Niwa; T Ogihara; J Yodoi; J Miyazaki
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  24 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Development of diabetes in lean Ncb5or-null mice is associated with manifestations of endoplasmic reticulum and oxidative stress in beta cells.

Authors:  Wenfang Wang; Ying Guo; Ming Xu; Han-Hung Huang; Lesya Novikova; Kevin Larade; Zhi-Gang Jiang; Terri C Thayer; Jennifer R Frontera; Daniel Aires; Helin Ding; John Turk; Clayton E Mathews; H Franklin Bunn; Lisa Stehno-Bittel; Hao Zhu
Journal:  Biochim Biophys Acta       Date:  2011-08-02

Review 3.  Comparative genetics: synergizing human and NOD mouse studies for identifying genetic causation of type 1 diabetes.

Authors:  John P Driver; Yi-Guang Chen; Clayton E Mathews
Journal:  Rev Diabet Stud       Date:  2012-12-28

4.  Is There a Role for Bioactive Lipids in the Pathobiology of Diabetes Mellitus?

Authors:  Undurti N Das
Journal:  Front Endocrinol (Lausanne)       Date:  2017-08-02       Impact factor: 5.555

5.  Methods to assess beta cell death mediated by cytotoxic T lymphocytes.

Authors:  Jing Chen; Scott Grieshaber; Clayton E Mathews
Journal:  J Vis Exp       Date:  2011-06-16       Impact factor: 1.355

6.  NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity.

Authors:  Hubert M Tse; Terri C Thayer; Chad Steele; Carla M Cuda; Laurence Morel; Jon D Piganelli; Clayton E Mathews
Journal:  J Immunol       Date:  2010-09-29       Impact factor: 5.422

7.  Genetic analysis of resistance to Type-1 Diabetes in ALR/Lt mice, a NOD-related strain with defenses against autoimmune-mediated diabetogenic stress.

Authors:  Clayton E Mathews; Robert T Graser; Rebecca J Bagley; Jason W Caldwell; Renhua Li; Gary A Churchill; David V Serreze; Edward H Leiter
Journal:  Immunogenetics       Date:  2003-09-25       Impact factor: 2.846

8.  Genetic control of non obese diabetic mice susceptibility to high-dose streptozotocin-induced diabetes.

Authors:  C Gonzalez; S Cuvellier; C Hue-Beauvais; M Lévi-Strauss
Journal:  Diabetologia       Date:  2003-07-15       Impact factor: 10.122

Review 9.  Role of increased ROS dissipation in prevention of T1D.

Authors:  Jing Chen; Aaron M Gusdon; Terri C Thayer; Clayton E Mathews
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

10.  Commonalities of genetic resistance to spontaneous autoimmune and free radical--mediated diabetes.

Authors:  Jing Chen; Ying Lu; Chul-Ho Lee; Renhua Li; Edward H Leiter; Clayton E Mathews
Journal:  Free Radic Biol Med       Date:  2008-07-31       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.